GMI Home Log In / Sign Up
Abstract Title:

Antidepressant-like effect of trans-resveratrol: Involvement of serotonin and noradrenaline system.

Abstract Source:

Eur Neuropsychopharmacol. 2010 Jun;20(6):405-13. Epub 2010 Mar 30. PMID: 20353885

Abstract Author(s):

Ying Xu, Zhichao Wang, Wenting You, Xiuhua Zhang, Shan Li, Philip A Barish, Matthew M Vernon, Xia Du, Gaowen Li, Jianchun Pan, William O Ogle

Article Affiliation:

J. Crayton Pruitt Family Department of Biomedical Engineering and Evelyn F.&William L. Mcknight Brain Institute, University of Florida, Gainesville, FL 32611, USA.


The antidepressant-like effect of trans-resveratrol, a phenolic compound present in polygonum cuspidatum, was evaluated through behavioral and neurochemical methods. trans-Resveratrol (20, 40 and 80 mg/kg, via gavage) significantly decreased the immobility time in mouse models of despair tests, but did not influence locomotor activity. Two behavioral models and neurochemical assays suggested that trans-resveratrol produced a significant increase in serotonin and noradrenaline levels at 40 or 80 mg/kg in brain regions. In addition, trans-resveratrol dose dependently inhibited MAO-A activity. These findings indicate that the antidepressant-like effect of trans-resveratrol might be related to serotonergic and noradrenergic activation.

Study Type : Animal Study

Print Options


Login to Comment

Commenting is limited to Members only. If you are already a member, please login to post a comment. If you do not have a member account and would like to become a member, please click here to begin the process to become a member.